Detalhe da pesquisa
1.
Intravenous Amisulpride Does Not Meaningfully Prolong the QTc Interval at Doses Effective for the Management of Postoperative Nausea and Vomiting.
Anesth Analg
; 132(1): 150-159, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31913911
2.
Amisulpride for the Rescue Treatment of Postoperative Nausea or Vomiting in Patients Failing Prophylaxis: A Randomized, Placebo-controlled Phase III Trial.
Anesthesiology
; 130(2): 203-212, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30475232
3.
Amisulpride in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy: a dose-escalation study.
Support Care Cancer
; 26(1): 139-145, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28801850
4.
Intravenous buspirone for the prevention of postoperative nausea and vomiting.
Eur J Clin Pharmacol
; 68(11): 1465-72, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22546895
5.
Metabolism and Excretion of Intravenous, Radio-Labeled Amisulpride in Healthy, Adult Volunteers.
Clin Pharmacol
; 11: 161-169, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31819674
6.
Host-Microbe Interactions: Winning the Colonization Lottery.
Curr Biol
; 27(13): R642-R644, 2017 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28697360